Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Cell-based immunotherapies (CBIs), notably exemplified by chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy, have emerged as groundbreaking approaches for cancer therapy. Nevertheless, akin to ...
Source: Journal of Biomedical Science - Category: Biomedical Science Authors: Yan-Ruide Li, Tyler Halladay and Lili Yang Tags: Review Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Cancer Therapy | Immunotherapy | Science